Ben F. Bulten

New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide

Wim van Boxtel, Ben F. Bulten, Annelies M. C. Mavinkurve‐Groothuis et al. · Biomarkers · 2015 · 60 citations

Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)

E J Reuvekamp, Ben F. Bulten, A A Nieuwenhuis et al. · Journal of Nuclear Cardiology · 2015 · 38 citations · Full text

Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients

Ben F. Bulten, Hein J. Verberne, Louise Bellersen et al. · Cancer Chemotherapy and Pharmacology · 2015 · 31 citations · Full text

Cardiac molecular pathways influenced by doxorubicin treatment in mice

Ben F. Bulten, Martina Sollini, Roberto Boni et al. · Scientific Reports · 2019 · 31 citations · Full text

Early myocardial deformation abnormalities in breast cancer survivors

Ben F. Bulten, Annelies M. C. Mavinkurve‐Groothuis, Lioe‐Fee de Geus‐Oei et al. · Breast Cancer Research and Treatment · 2014 · 13 citations

Heart Failure, Breast Oncology, Medicine +6